Commercial Pharmaceutical Analytics Market Analysis

  • Report ID: 2834
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Pharmaceutical Analytics Segmentation

Type (Descriptive, Predictive, Prescriptive Analytics)

The global commercial pharmaceutical analytics market is segmented and analyzed for demand and supply by type into descriptive, predictive, and prescriptive analytics. Out of these segments, the descriptive analytics segment is estimated to gain the largest market share in the year 2037. The growth of the segment can be attributed to the increasing adoption of big data analytical techniques and the benefits offered by the technique in the analytical space. Descriptive analytics is the most common form of analytics used by most pharmaceutical organizations. This type of analytical technique analyzes the information that is coming progressively or from past records. The technique is also used to discover explanations for valuable achievements or past failures. Additionally, descriptive analytics is also considered to be beneficial to check drug efficiency, therefore, the surge in the development of novel drugs is also anticipated to propel the market growth over the forecast period. For instance, the Center for Drug Evaluation and Research (CDER), approved more than 35 drugs in 2022, 50 drugs in 2021, and 60 drugs in 2018.

Application (R&D, Marketing & Sales, Supply Chain Optimization, Internal Reporting)

The global commercial pharmaceutical analytics market is also segmented and analyzed for demand and supply by application into R&D, marketing & sales, supply chain optimization, and internal reporting. Amongst these segments, the R&D segment is expected to garner a significant share in the year 2037. The growth of the segment can be ascribed to the rapidly growing pharmaceutical industry globally coupled with increasing demand for advanced therapies and drugs, along with the rising research and development expenditure by the government of nations worldwide. The surge in clinical trials across the globe to find a cure for various types of diseases and disorders is also anticipated to hike the growth of the R&D segment during the forecast period.

Our in-depth analysis of the global market includes the following segments:

         By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

         By Application

  • R&D
  • Marketing & Sales
  • Supply Chain Optimization
  • Internal Reporting

          By Deployment

  • On-Premises
  • Web-Based/Cloud Based

          By Components

  • Software
  • Services

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of commercial pharmaceutical analytics is estimated at USD 42.05 billion.

The commercial pharmaceutical analytics market size was over USD 33.33 billion in 2024 and is poised to exceed USD 214.54 billion by 2037, growing at over 15.4% CAGR during the forecast period i.e., between 2025-2037. The growing inclination of pharma companies towards advertising and increasing sales volume of over-the-counter medicines will boost the market growth.

North America industry is likely to dominate majority revenue share of 31% by 2037, propelled by increasing pharmaceutical sales in the region.

The major players in the market are CitiusTech Inc., SAS Institute Inc., ExlService Holdings, Inc., Oracle Corporation, International Business Machines Corporation, Northwest Analytics, Inc., Navitas Life Sciences, TATA Consultancy Services Limited, Dassault Systèmes S.E., Wipro Limited
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos